Bacterial 'sabotage' handicaps ability to resolve devastating lung inflammation
The chronic lung inflammation that is a hallmark of cystic fibrosis, has, for the first time, been linked to a new class of bacterial enzymes that hijack the patient's immune response and prevent the body from calling off ...